• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

来自三个治疗组的删失生存数据的序贯分析。

Sequential analysis of censored survival data from three treatment groups.

作者信息

Betensky R A

机构信息

Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts 02115, USA.

出版信息

Biometrics. 1997 Sep;53(3):807-22.

PMID:9333347
Abstract

In this paper, we propose a simple means of designing and analyzing a sequential procedure for comparing survival data from three treatments with the goal of eventually identifying the best treatment. Our procedure consists of the concatenation of two sequential tests, as is suggested by Siegmund (1993, Annals of Statistics 21, 464-483) for instantaneous normal responses. The first sequential test is a global test that attempts to detect an overall treatment effect. If one is found, the least promising treatment is eliminated and a second sequential test attempts to identify the better of the two remaining treatments. Although there are three different information time scales to consider corresponding to each pairwise comparison, we show that under certain conditions they may be approximated by a single time scale. This enables us to gain insight into the problem of censored survival data from the more easily understood case of instantaneous normal data. Also, it eliminates the need for intensive computations and simulations for the design and analysis of the procedure.

摘要

在本文中,我们提出了一种简单的方法,用于设计和分析一种序贯程序,以比较三种治疗方法的生存数据,最终目标是确定最佳治疗方法。我们的程序由两个序贯检验串联组成,这是西格蒙德(1993年,《统计学年鉴》21卷,464 - 483页)针对瞬时正态反应所建议的。第一个序贯检验是一个全局检验,旨在检测总体治疗效果。如果发现有总体治疗效果,那么最没有前景的治疗方法将被剔除,然后进行第二个序贯检验,以确定剩下的两种治疗方法中哪一种更好。尽管对于每一对比较都有三种不同的信息时间尺度需要考虑,但我们表明在某些条件下,它们可以由单个时间尺度近似。这使我们能够从更容易理解的瞬时正态数据案例中深入了解删失生存数据的问题。此外,这也消除了对该程序的设计和分析进行密集计算和模拟的必要性。

相似文献

1
Sequential analysis of censored survival data from three treatment groups.来自三个治疗组的删失生存数据的序贯分析。
Biometrics. 1997 Sep;53(3):807-22.
2
Design and analysis of group sequential logrank tests in maximum duration versus information trials.最大持续时间与信息量试验中序贯对数秩检验的设计与分析
Biometrics. 1995 Sep;51(3):988-1000.
3
A group-sequential design for clinical trials with treatment selection.一种用于有治疗选择的临床试验的序贯分组设计。
Stat Med. 2008 Dec 20;27(29):6209-27. doi: 10.1002/sim.3436.
4
A note on the power of Fisher's least significant difference procedure.关于费舍尔最小显著差异法功效的一则注释。
Pharm Stat. 2006 Oct-Dec;5(4):253-63. doi: 10.1002/pst.210.
5
A two-stage procedure for survival studies with surrogate endpoints.
Biometrics. 1995 Sep;51(3):969-76.
6
A multiple-step selection procedure with sequential protection of preferred treatments.
Biometrics. 1993 Sep;49(3):753-61.
7
Nonparametric regression estimates with censored data: local linear smoothers and their applications.含删失数据的非参数回归估计:局部线性平滑方法及其应用
Biometrics. 1998 Dec;54(4):1434-44.
8
Chop-lump tests for vaccine trials.疫苗试验的砍块试验。
Biometrics. 2009 Sep;65(3):885-93. doi: 10.1111/j.1541-0420.2008.01131.x. Epub 2009 Feb 5.
9
A method for sequential analysis of survival data with nonproportional hazards.一种用于非比例风险生存数据序贯分析的方法。
Biometrics. 1998 Sep;54(3):1072-84.
10
An implicitly defined parametric model for censored survival data and covariates.一种针对删失生存数据和协变量的隐式定义参数模型。
Biometrics. 1995 Mar;51(1):249-58.

引用本文的文献

1
Statistical monitoring of clinical trials with multivariate response and/or multiple arms: a flexible approach.具有多变量反应和/或多个试验组的临床试验的统计监测:一种灵活的方法。
Biostatistics. 2009 Apr;10(2):310-23. doi: 10.1093/biostatistics/kxn037. Epub 2008 Nov 16.